COSCIENS Biopharma Inc. CSCIF
Terms unclear
Unclear — read the filing yourself
| Status | Open |
|---|---|
| Closing date | could not be read; last filing 2026-05-04 |
| How it is priced | — |
| Odd-lot threshold | — |
| Must tender everything you hold | Not stated |
| Must tick the odd-lot box on the form | Not stated |
Where each of these comes from
Every line above was read out of the filing. Here is the wording it was read from, so you can check it.
listed = True...he Committee. ● All members must be financially literate as defined in accordance with applicable securities laws and standards of the stock exchanges on which the Corporation’s securities are listed. ● In addition, for as long as the Corporation’s securities are listed on the Nasdaq Stock Market, at least one member of the Committee must have past employment experience in finance or accounting, requisite professional certification in accounting, or any other comparable experience or background which results in the individual’s financial sophistication. ● The chairperson of the Committee shall be appointed by the Board from time...
listed = True...he Committee. ● All members must be financially literate as defined in accordance with applicable securities laws and standards of the stock exchanges on which the Corporation’s securities are listed. ● In addition, for as long as the Corporation’s securities are listed on the Nasdaq Stock Market, at least one member of the Committee must have past employment experience in finance or accounting, requisite professional certification in accounting, or any other comparable experience or background which results in the individual’s financial sophistication. ● The chairperson of the Committee shall be appointed by the Board from time...
txn_type = CONSOLIDATION...financial statements of the Corporation, together with the auditor’s report thereon, for the fiscal year ended December 31, 2025; (ii) to elect directors of the Corporation; (iii) to appoint Deloitte LLP as auditors of the Corporation; and (iv) to approve the Share Capital Amendment (as defined below). See “Particulars of Matters to be Acted Upon”. The record date for the determination of Shareholders of COSCIENS entitled to receive notice of, and to vote at, the Meeting is [_______], 2026. See “Information Concerning Voting at the Meeting”. Receiving the Financial Statements The audited financial statements of the...
txn_type = CONSOLIDATION...financial statements of the Corporation, together with the auditor’s report thereon, for the fiscal year ended December 31, 2025; (ii) to elect directors of the Corporation; (iii) to appoint Deloitte LLP as auditors of the Corporation; and (iv) to approve the Share Capital Amendment (as defined below). See “Particulars of Matters to be Acted Upon”. The record date for the determination of Shareholders of COSCIENS entitled to receive notice of, and to vote at, the Meeting is [_______], 2026. See “Information Concerning Voting at the Meeting”. Receiving the Financial Statements The audited financial statements of the...
The filings
| Filed | Form | Role | On EDGAR |
|---|---|---|---|
| 2026-04-20 | SC 13E3 | original (governing) | View |
| 2026-05-04 | SC 13E3/A | amendment | View |